MétaCan
Menu
Back to cohort
Record W4392516312 · doi:10.1080/19420862.2024.2323706

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge

2024· article· en· W4392516312 on OpenAlexafffund
Michael Biddle, Panayiota Stylianou, Marek Rękas, Adam Wright, Jaize Viana Ribeiro Sousa, David A. Ruddy, M. Irina Stefana, Katarzyna Kmiecik, Anita Bandrowski, Richard Kahn, Carl Laflamme, Eva M. Krockow, Harvinder Virk

Bibliographic record

VenuemAbs · 2024
Typearticle
Languageen
FieldImmunology and Microbiology
TopicBiosimilars and Bioanalytical Methods
Canadian institutionsMcGill UniversityStructural Genomics ConsortiumMontreal Neurological Institute and Hospital
FundersNIHR Leicester Biomedical Research CentreBiotechnology and Biological Sciences Research CouncilNational Institute of General Medical SciencesDirectorate for Biological SciencesOntario GenomicsNational Institute for Health and Care ResearchGenome Canada
KeywordsContext (archaeology)Computer scienceQuality (philosophy)ExploitData scienceBiochemical engineeringRisk analysis (engineering)BusinessEngineeringComputer securityBiology

Abstract

fetched live from OpenAlex

Antibodies are one of the most important reagents used in biomedical and fundamental research, used to identify, and quantify proteins, contribute to knowledge of disease mechanisms, and validate drug targets. Yet many antibodies used in research do not recognize their intended target, or recognize additional molecules, compromising the integrity of research findings and leading to waste of resources, lack of reproducibility, failure of research projects, and delays in drug development. Researchers frequently use antibodies without confirming that they perform as intended in their application of interest. Here we argue that the determinants of end-user antibody choice and use are critical, and under-addressed, behavioral drivers of this problem. This interacts with the batch-to-batch variability of these biological reagents, and the paucity of available characterization data for most antibodies, making it more difficult for researchers to choose high quality reagents and perform necessary validation experiments. The open-science company YCharOS works with major antibody manufacturers and knockout cell line producers to characterize antibodies, identifying high-performing renewable antibodies for many targets in neuroscience. This shows the progress that can be made by stakeholders working together. However, their work so far applies to only a tiny fraction of available antibodies. Where characterization data exists, end-users need help to find and use it appropriately. While progress has been made in the context of technical solutions and antibody characterization, we argue that initiatives to make best practice behaviors by researchers more feasible, easy, and rewarding are needed. Global cooperation and coordination between multiple partners and stakeholders will be crucial to address the technical, policy, behavioral, and open data sharing challenges. We offer potential solutions by describing our Only Good Antibodies initiative, a community of researchers and partner organizations working toward the necessary change. We conclude with an open invitation for stakeholders, including researchers, to join our cause.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.602
metaresearch head score (Gemma)0.690
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Research integrity
Consensus categoriesMetaresearch
DomainCandidate signal: Reproducibility · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.985
Threshold uncertainty score0.491

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6020.690
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0060.009
Science and technology studies0.0060.029
Scholarly communication0.0360.033
Open science0.0120.017
Research integrity0.0150.021
Insufficient payload (model declined to judge)0.0070.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.332
GPT teacher head0.485
Teacher spread0.153 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
DomainReproducibility
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2024
Admission routes2
Has abstractyes

Explore more

Same venuemAbsSame topicBiosimilars and Bioanalytical MethodsFrench-language works237,207